Boston Scientific sells old Natick HQ; Stryker finds a new CFO;

 @FierceMedDev: 'Awake Imaging' boosts Dx prospects for fidgety patients. Article | Follow @FierceMedDev

 @MarkHFierce: BSD will use Japan's Terumo to reach global markets with its cancer ablation device. More | Follow @MarkHFierce

 @DamianFierce: Quintiles' founder and early investors will make off with $25M once the CRO goes public. Story | Follow @DamianFierce

> Boston Scientific ($BSX) has sold its old Natick, MA, headquarters to software company Math Works for $55 million. The devicemaker is in the process of relocating to nearby Marlborough. Article

> Stryker ($SYK) has appointed a new CFO, recruiting former Dentsply International vice president William Jellison. More

> Medimetrics has joined the Netherlands' Nizo Food Research to use its IntelliCap device to conduct in vivo tests of gastric responses to foods. Article

> About 30% of medical device startups plan to pass along most or all of the device tax's increase costs, according to the Startup Outlook 2013 survey; while 77% of those surveyed say they plan to hire this year. Story

> Monteris Medical gained a second FDA 510(k) clearance for its second-generation NeuroBlate MRI-guided ablation device to treat brain tumors and other lesions. Item

> Amarantus Bioscience plans to begin a small clinical performance study using its LymPro blood test to diagnose Alzheimer's disease in the fiscal 2013 second quarter, with a pivotal study likely later in the year. Release

> Medical device approvals climbed 7% from 2011 to 2012, due to increased demand from an aging population. Story

Biotech News

 @FierceBiotech: Pharmacyclics bounces higher as J&J wins third 'breakthrough' cancer drug coup. More | Follow @FierceBiotech

 @JohnCFierce: Roche rolls out $392M Isis pact in two-prong attack on Huntington's. Story | Follow @JohnCFierce.

 @RyanMFierce: Uh oh. biotech outfit Unigene is slashing ~40% of workers to extend cash runway. Release | Follow @RyanMFierce

> Investigator says 'insane' rules are blocking his study on magic mushrooms. More

> Blue chip venture groups arm gene therapy upstart with $41M launch round. News

> In Sunday surprise, Bristol-Myers' R&D chief replaced by lieutenant. Report

Pharma News

 @FiercePharma: Merck's new Fosamax trial starts today. Was woman's atypical femur fracture caused by drug, or disease? More | Follow @FiercePharma

 @EricPFierce: India delays to 2014 its deadline for drugmakers to put bar codes on primary packaging to fight fakes. More | Follow @EricPFierce

> Merz drops out of Obagi bidding, handing $417M deal to Valeant. News

> U.S. drugmakers Pfizer, J&J top reputation ranks in Germany, Italy. Story

> Orphan drugs join the price-squeeze club in Europe. Report

CRO News

> InVentiv sells sample management biz to Knipper. More

> Indian trial reform on the way, but does it make sense? Article

> EU CRO TranScrip launches U.S. operation. Item

> AmerisourceBergen sells contract packaging biz for $308M. More

> Bristol-Myers picks LabCorp for CRO work. Story

Biotech IT News

> Survey: Cloud computing tops pharma's IT plans. More

> Life Tech genome software aids cancer-drug hunters in pharma. Report

> New trial search engine steps into congested market. Story

> Big Data hits Eastern Europe as IBM fires up supercomputer. Item

> Computational scientists clear path to potential Parkinson's drugs. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.